1. Performing tests that are not medically necessary is a major problem in clinical laboratories. What steps does the OIG recommend that labs take to prevent this? (list/number the steps – explain the steps) 2. The OIG recommends that labs
HEALTHCARE COMPLIANCE II
In Chapter 8, we studied the compliance program in general, this chapter takes the structure of a healthcare compliance program, and applies it to a hospital. Hospitals are subject to the same law as healthcare organizations. Aspects of these laws
HEALTHCARE COMPLIANCE II
In Chapter 8, we studied the compliance program in general, this chapter takes the structure of a healthcare compliance program, and applies it to a hospital. Hospitals are subject to the same law as healthcare organizations. Aspects of these laws
HEALTHCARE COMPLIANCE II
1. https://www.youtube.com/watch?v=Wlsnd1DYG6Y 2. https://www.youtube.com/watch?v=-O5gsF5oyls Questions: Please answer the following 5 questions and post your response. Thank you! 1.What are some of the reasons that the Federal government wishes to regulate research institutions? 2. The NIH has published mandatory standards designed
HEALTHCARE COMPLIANCE II
1. https://www.youtube.com/watch?v=Wlsnd1DYG6Y 2. https://www.youtube.com/watch?v=-O5gsF5oyls Questions: Please answer the following 5 questions and post your response. Thank you! 1.What are some of the reasons that the Federal government wishes to regulate research institutions? 2. The NIH has published mandatory standards designed
HEALTHCARE COMPLIANCE II
Please answer the following question and post your response Thank you! The OIG Compliance Program Guidance for DMEPOS entities lists 47 areas of special concern to the OIG. This is far more compliance risk areas than appear in the program
HEALTHCARE COMPLIANCE II
Links to the website article 1.https://www.nytimes.com/2012/07/03/business/glaxosmithkline-agrees-to-pay-3-billion-in-fraud-settlement.html?pagewanted=all 2. https://www.youtube.com/watch?v=hI_EbSPWUgI 3. https://www.youtube.com/watch?v=Y8GrtP0ln9o Are fines enough? As dramatic as the $3 billion fine appears for GlaxoSmithKline, there are some who believe it was not enough. There are those who advocate making the consequences
HEALTHCARE COMPLIANCE II
. What is the difference between Medicare Advantage and traditional Medicare? 2. What is a special investigation unit (SIU)? 3. Under certain circumstances, the CMS may wish to perform its own audits of a Sponsor’s or FDR’s activities pertaining to
HEALTHCARE COMPLIANCE II
. What is the difference between Medicare Advantage and traditional Medicare? 2. What is a special investigation unit (SIU)? 3. Under certain circumstances, the CMS may wish to perform its own audits of a Sponsor’s or FDR’s activities pertaining to
HEALTHCARE COMPLIANCE II
Please answer the following 4 questions Thank you! 1. What are the reasons that health care providers contract with third-party billing companies to submit their claims for reimbursement from payors such as Medicare? 2. The compliance concerns of the billing